Back to News
Market Impact: 0.2
Pulse Biosciences Partners With Clayman Thyroid Center To Expand Thyroid Nodule Treatment
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
Pulse Biosciences entered a commercial and clinical partnership with the Clayman Thyroid Center at the Hospital for Endocrine Surgery in Tampa, Florida. The partnership aims to expand patient access to Pulse’s nPulse Vybrance System for benign thyroid nodules; the provided article text gives no financial terms or additional details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
PLSE0.55
More News
- Anthropic's third-quarter revenue is said to hit $16.8 billion ahead of IPO
- SK Hynix seeks U.S. chip equipment exports to China tied to new factory
- Dell stock plunges 11%, leading data center sell-off on concerns about 'enterprise AI timing'
- Why is Netwealth stock sliding today?
- Bending Spoons skyrockets 35% as Berkshire Hathaway makes $330 million investment
- Bending Spoons Stock Soars on Berkshire’s Increased Stake